Co-medication with cannabidiol temporarily slowed progression of amyotrophic lateral sclerosis
Co-medication with cannabidiol was able to improve significant symptoms in a patient with amyotrophic lateral sclerosis according to an article by an Austrian scientist. He wrote that “about eighteen months ago, the patient, a general practitioner at the beginning of his sixties, observed a painless weakness and impaired function of his right hand.” Despite treatment with riluzole, symptoms progressed relatively fast. Therefore, the patient decided to take cannabidiol (CBD, 2 × 200 mg/day) as co-medication and increased to a daily dose of 2 × 300 mg.
The author wrote, “Within 6 weeks, the impaired function of the right hand and foot reversed almost completely and dysphagia [impaired food intake] partially. Improvement was maintained for about 10 weeks, when again a slow progression” of symptoms was observed.
